BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37137792)

  • 1. Mitochondria in cancer stem cells: Achilles heel or hard armor.
    Zheng XX; Chen JJ; Sun YB; Chen TQ; Wang J; Yu SC
    Trends Cell Biol; 2023 Aug; 33(8):708-727. PubMed ID: 37137792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy.
    Praharaj PP; Panigrahi DP; Bhol CS; Patra S; Mishra SR; Mahapatra KK; Behera BP; Singh A; Patil S; Bhutia SK
    Cancer Lett; 2021 Feb; 498():217-228. PubMed ID: 33186655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies.
    Skoda J; Borankova K; Jansson PJ; Huang ML; Veselska R; Richardson DR
    Pharmacol Res; 2019 Jan; 139():298-313. PubMed ID: 30453033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer.
    Mukherjee S; Bhatti GK; Chhabra R; Reddy PH; Bhatti JS
    Biomed Pharmacother; 2023 Apr; 160():114398. PubMed ID: 36773523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Mitochondria in Cancer Stem Cell Resistance.
    García-Heredia JM; Carnero A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial biology in cancer stem cells.
    Loureiro R; Mesquita KA; Magalhães-Novais S; Oliveira PJ; Vega-Naredo I
    Semin Cancer Biol; 2017 Dec; 47():18-28. PubMed ID: 28673608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: Novel mechanism for anti-cancer stem cell-targeted cancer therapy.
    Praharaj PP; Patro BS; Bhutia SK
    Br J Pharmacol; 2022 Nov; 179(22):5015-5035. PubMed ID: 33527371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitostemness.
    Cuyàs E; Verdura S; Folguera-Blasco N; Bastidas-Velez C; Martin ÁG; Alarcón T; Menendez JA
    Cell Cycle; 2018; 17(8):918-926. PubMed ID: 29886796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening identifies artesunate as selective inhibitor of cancer stemness: Involvement of mitochondrial metabolism.
    Subedi A; Futamura Y; Nishi M; Ryo A; Watanabe N; Osada H
    Biochem Biophys Res Commun; 2016 Sep; 477(4):737-742. PubMed ID: 27363336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dynamics in cancer stem cells.
    Sessions DT; Kashatus DF
    Cell Mol Life Sci; 2021 Apr; 78(8):3803-3816. PubMed ID: 33580834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabostemness in cancer: Linking metaboloepigenetics and mitophagy in remodeling cancer stem cells.
    Naik PP; Panigrahi S; Parida R; Praharaj PP; Bhol CS; Patil S; Manjunath N; Ghosh D; Patra SK; Bhutia SK
    Stem Cell Rev Rep; 2022 Jan; 18(1):198-213. PubMed ID: 34355273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cells and Targeting Strategies.
    Barbato L; Bocchetti M; Di Biase A; Regad T
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.
    Genovese I; Carinci M; Modesti L; Aguiari G; Pinton P; Giorgi C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of mitochondria in liver cancer stem cells.
    Chang CW; Lo JF; Wang XW
    Differentiation; 2019; 107():35-41. PubMed ID: 31176254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for targeting cancer stem cells drug resistance.
    Rosa R; D'Amato V; De Placido S; Bianco R
    Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.